CD40LG and rheumatoid arthritis: Anti-MAA positivity in RA participants ranged from 6%-91% for IgG (21, 30, 31, 33, 34, 37–39), 7.2%-73% for IgA (21, 30, 38), and 0.6%-38% for IgM (21, 30, 38).